Lobbying disclosures · Lobbying report
ABT: second_quarter 2026 lobbying report
Issues related to S. 1821 - Tackling Predatory Litigation Funding Act; Issues related to S. 2003 - Strengthening Benefits Plan Act. Issues related to S. 2003 - Strengthening Benefits Plan Act.
Follow ABT- Became public
- Jul 20, 2026, 12:45 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 9:48 AM EST
Why this is connected
Exact legal-name match: ABBOTT LABORATORIES (https://www.sec.gov/Archives/edgar/data/1800/).
Reported lobbying amounts
Income: $50,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/f28d823d-6ddb-4f8a-b950-a9512feaa347/","filing_uuid":"f28d823d-6ddb-4f8a-b950-a9512feaa347","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/f28d823d-6ddb-4f8a-b950-a9512feaa347/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brendan Dunn","dt_posted":"2026-07-20T12:45:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"519 Lee Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":401108637,"url":"https://lda.gov/api/v1/registrants/401108637/","house_registrant_id":56535,"name":"PHRONESISDC, LLC","description":null,"address_1":"519 Lee Street","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENDAN DUNN","contact_telephone":"+1 703-477-5970","dt_updated":"2026-07-30T09:19:36.633037-04:00"},"client":{"id":72861,"url":"https://lda.gov/api/v1/clients/72861/","client_id":72861,"name":"ABBOTT LABORATORIES","general_description":"Leader in disease prevention, care, management, testing, and other global health issues.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-04-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to S. 1821 - Tackling Predatory Litigation Funding Act; Issues related to S. 2003 - Strengthening Benefits Plan Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146519,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":null,"last_name":"DUNN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"RET","general_issue_code_display":"Retirement","description":"Issues related to S. 2003 - Strengthening Benefits Plan Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146519,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":null,"last_name":"DUNN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in ABT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 27, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 18, 2026 · Spouse
Committee overlap: Energy and CommerceTraded 2 days before earnings - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Got $2K from the company’s PAC - Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.